We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Health Monitoring Campaign Launched

By LabMedica International staff writers
Posted on 11 Feb 2014
Print article
A DNA health test aims to assist in prevention of diseases associated with DNA damage and poor DNA repair.

The Berkeley-based startup, Exogen Biotechnology (CA, USA), has launched a unique citizen science campaign on Indiegogo, a global “crowd funding” website (San Francisco, CA, USA). The campaign is based on a laboratory test, which measures DNA breaks, the most lethal type of DNA damage and a potentially key indicator for overall health conditions. Launched on January 25, 2013, the project raised USD 20,000 in “crowd funding” within its first three days.

The technology measures physical breaks in the DNA of cells, which commonly result from an individual's lifestyle, environmental toxins, or personal genetics. The startup from the Lawrence Berkeley National Laboratory envisions that its DNA health monitoring technology will one day be as commonplace as a cholesterol test. The DNA health test aims to assist in prevention of diseases associated with DNA damage and poor DNA repair.

Exogen is allowing the public to assist in funding its large-scale citizen scientist project as well as gain access to the technology that is not yet available to the public. Supporters receive a kit that allows funders to safely collect three blood samples via sterile finger pricks. Blood samples are then mailed to Exogen’s proprietary research lab and analyzed either as a one-time event or on a regular basis throughout the year. The blood is processed for DNA damage and the results are made available back to the funder, securely and privately via a protected web application.

The core team behind the project is comprised of Dr. Sylvain Costes and Dr. Jonathan Tang, who are experts in understanding the link between ionizing radiation, DNA damage, and cancer induction. They developed this leading-edge technology over the past 10 years at the Lawrence Berkeley National Laboratory.

Dr. Tang commented, “Breaks in our DNA occur frequently, and our bodies repair them every day. However, as we age, the efficiency of how our bodies repair DNA breaks seems to weaken. This decline in repair efficiency can lead to accumulation of unrepaired DNA or misrepaired DNA, which may result in unpredictable and potentially lethal genetic mutations. Exogen hopes that monitoring DNA for breaks will allow individuals to assess the impact of various lifestyles and environments on their overall health and aging.”

Related Links:

Exogen Biotechnology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.